Evidence map›Paper›PMID 26438331›Full record

ArticleCytotechnology2016

Astrocyte/neuron ratio and its importance on glutamate toxicity: an in vitro voltammetric study.

Ahmet Hacimuftuoglu, Abdulgani Tatar, Damla Cetin, Numan Taspinar, Fatih Saruhan, Ufuk Okkay, Hasan Turkez, Deniz Unal, Robert Louis Stephens, Halis Suleyman

Abstract read
In one paragraph

Article in Cytotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer's Disease APP/PS1 Mouse Model.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ahmet HacimuftuogluDepartment of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey. ahmeth@atauni.edu.tr.
Abdulgani TatarDepartment of Medical Genetics, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Damla CetinDepartment of Medical Pharmacology, Faculty of Medicine, Kafkas University, Kars, Turkey.
Numan TaspinarDepartment of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Fatih SaruhanDepartment of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Ufuk OkkayDepartment of Medical Pharmacology, Faculty of Medicine, Atatürk University, Erzurum, Turkey.
Hasan TurkezDepartment of Molecular Biology and Genetics, Faculty of Sciences, Erzurum Technical University, Erzurum, Turkey.
Deniz UnalDepartment of Histology, Faculty of Medicine, Ataturk University, Erzurum, Turkey.
Robert Louis StephensDepartment of Physiology and Cell Biology, Medical College, The Ohio State University, Columbus, OH, USA.
Halis SuleymanDepartment of Medical Pharmacology, Faculty of Medicine, Erzincan University, Erzincan, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to clarify the relationship between neuron cells and astrocyte cells in regulating glutamate toxicity on the 10th and 20th day in vitro. A mixed primary culture system from newborn rats that contain cerebral cortex neurons cells was employed to investigate the glutamate toxicity. All cultures were incubated with various glutamate concentrations, then viability tests and histological analyses were performed. The activities of glutamate transporters were determined by using in vitro voltammetry technique. Viable cell number was decreased significantly on the 10th day at 10(-7) M and at 10(-6) M glutamate applications, however, viable cell number was not decreased at 20th day. Astrocyte number was increased nearly six times on the 20th day as compared to the 10th day. The peak point of glutamate reuptake capacity was about 2 × 10(-4) M on the 10th day and 10(-3) M on the 20th day. According to our results, we suggested that astrocyte age was important to maintain neuronal survival against glutamate toxicity. Thus, we revealed activation or a trigger point of glutamate transporters on astrocytes due to time since more glutamate was taken up by astrocytes when glutamate transporters on the astrocyte were triggered with high exogenous glutamate concentrations. In conclusion, the present investigation is the first voltammetric study on the reuptake parameters of glutamate in vitro.

Indexed as

AstrocyteGlutamate-uptakeIn vitro voltammetryNeuronNeurotoxicity

Identifiers

PMID26438331
PMCPMC4960189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.